25th Annual EuroMeeting

Back to Agenda

ASIAN STRATEGY OF THE USA, EUROPE AND JAPAN

Session Chair(s)

Nobumasa Nakashima

Health Policy Director, National Healthcare Policy Secretariat

Cabinet Office, Japan

Asia is gaining in importance in drug development, production, and marketing. This session discusses the efforts by the regulatory authorities and industry from Japan, US and EU to promote drug development in Asia and global cooperation at the international community.

Learning Objective : (1) To understand how leading international regulatory harmonization initiatives are functioning (2) To discuss future directions of harmonization activities

Speaker(s)

International Cooperation and Consideration on Multi-Regional Clinical Trial among Asia

Shinobu Uzu, PhD

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Senior Executive Director

Asia – the world’s fastest growing market: perspective from the pharmaceutical industry

Ira Wolf, MA

Pharmaceutical Research and Manufacturers of America (PhRMA), United States

Japan Representative

Challenges to Asian Companies to Comply with European Legislation on (Traditional) Herbal Medicinal Products

Werner Knoess, DrSc

BfArM, Germany

Head of Department/BfArM and Chair of the HMPC/EMA

Have an account?